Saturday, March 18, 2006
8:00 - 9:05 am Session I: Prevention, Screening & the High Risk Patient
Moderator: Dr. Funmi Olopade

1. How I Manage the High Risk Patient - Dr. Funmi Olopade
2. Update on Prevention - Dr. Claudine Isaacs

9:05 am - 3:15 pm Session II: Management of Early Breast Cancer
Moderator: Dr. Hyman Muss

1. The Role of Radiation in Improving Survival - Dr. Timothy Whelan
2. Hormone Therapy for Early Stage Breast Cancer:
   Challenges in the Treatment of Premenopausal Women - Dr. Hope Rugo
3. Hormonal Therapy in Post-Menopausal Women - Dr. Hyman Muss
4. Optimizing Chemotherapy for Node Negative Patients - Dr. Stefan Glück
5. Case Presentation - Dr. John Pippen
6. Adjuvant Chemotherapy Debate: Dose Dense Chemotherapy - Dr. Cliff Hudis
7. Adjuvant Chemotherapy Debate: Alternative Strategies to Dose Dense Therapy - Dr. Charles Vogel
8. The Added Value of Chemotherapy in Women with ER+ Breast Cancer - Dr. Peter Ravdin
9. Young Women & Breast Cancer: Pregancy and Fertility - Dr. Ann Partrige

3:15 - 4:45 pm Session III: Metastic Breast Cancer
Moderator: Dr. John Pippen

1. Beyond Herceptin: The New Biologics - Dr. George Sledge
2. Metastatic Disease Chemotherapy Debate: Single Agents - Dr. Eric Winer
3. Metastatic Disease Chemotherapy Debate: Combination Chemotherapy - Dr. Howard Burris

Sunday, March 19, 2006
8:00 am - 12:00 pm Session IV: New Treatments & Management of Toxcity
Moderator: Dr. Mark Pegram

1. A Patient - Centered Vision of Quality Breast Cancer Care - Ms. Carolina Hinestrosa
2. Role of Herceptin in Breast Cancer - Dr. Mark Pegram
3. How I Use MRI and Other Imaging To Manage High-Risk Patients - Dr. Ellen Warner
4. How I Use Growth Factors - Dr. Harold Burstein
5. How I Use Antimetics - Dr. Steven Grunberg
6. Case Presentations - Dr. John Pippen